Even if these findings are secondary to TET2 loss in another cell type, they still have potential relevance to diseases regulated by IgMs produced by B-1 cells such as infection (71–77), atherosclerosis (78–84), and obesity-related metabolic dysfunction (85, 86). The gene discussed is TET2; the disease is obesity disorder.